Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Proposed Acquisition of European Medical Testing Subsidiary (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News FibroGen Inc FGEN

Healthcare Biotechnology
FibroGen, Inc. is a biopharmaceutical company. The Company is engaged in developing and commercializing a diversified pipeline of novel therapeutics that work at the frontiers of cancer biology and anemia. Its clinical, commercial, and research programs include Pamrevlumab, which is a first-in-class antibody being developed by FibroGen to inhibit the activity of connective tissue growth factor ... see more

Recent & Breaking News (NDAQ:FGEN)

Astellas Submits New Drug Application in Japan of Roxadustat for The Treatment of Anemia Associated with Chronic Kidney Disease in Patients on Dialysis

GlobeNewswire October 1, 2018

FibroGen Receives Fast Track Designation From the U.S. FDA for Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis

GlobeNewswire September 12, 2018

New Research: Key Drivers of Growth for comScore, Fonar, FibroGen, Resolute Energy, National Commerce, and THL Credit — Factors of Influence, Major Initiatives and Sustained Production

GlobeNewswire August 15, 2018

FibroGen Reports Second Quarter 2018 Financial Results

GlobeNewswire August 7, 2018

FibroGen to Report Second Quarter 2018 Financial Results on Tuesday, August 7, 2018

GlobeNewswire August 1, 2018

FibroGen Announces Completion of Enrollment in U.S. Phase 3 Clinical Program for Roxadustat in Anemia Associated with Chronic Kidney Disease

GlobeNewswire June 7, 2018

FibroGen to Present at Two Upcoming Investor Conferences

GlobeNewswire June 4, 2018

FibroGen Presents Clinical Results of Pamrevlumab Treatment in Patients with Locally Advanced Unresectable Pancreatic Cancer at ASCO 2018 Annual Meeting

GlobeNewswire June 3, 2018

FibroGen Reports First Quarter 2018 Financial Results

GlobeNewswire May 9, 2018

FibroGen to Report First Quarter 2018 Financial Results on Wednesday, May 9, 2018

GlobeNewswire May 2, 2018

UPDATE - FibroGen Granted Fast Track Designation by U.S. FDA for Pamrevlumab Treatment of Patients with Locally Advanced Unresectable Pancreatic Cancer

GlobeNewswire March 1, 2018

Report: Developing Opportunities within Main Street Capital, United States Cellular, FibroGen, Cardiovascular, CDW, and ANSYS — Future Expectations, Projections Moving into 2018

GlobeNewswire March 1, 2018

Fibrogen Granted Fast Track Designation by U.S. FDA for Pamrevlumab Treatment of Patients with Locally Advanced Unresectable Pancreatic Cancer

GlobeNewswire March 1, 2018

FibroGen Reports Fourth Quarter and Full Year 2017 Financial Results

GlobeNewswire February 27, 2018

FibroGen, Inc. to Host Earnings Call

Accesswire February 27, 2018

FibroGen Q4 Earnings Outlook

Benzinga.com  February 27, 2018

FibroGen to Report Fourth Quarter and Full Year 2017 Financial Results on Tuesday, February 27, 2018

GlobeNewswire February 21, 2018

FibroGen Reports Third Quarter 2017 Financial Results

GlobeNewswire November 8, 2017

FibroGen, Inc. to Host Earnings Call

Accesswire November 8, 2017

FibroGen to Report Third Quarter Financial Results on Wednesday, November 8, 2017

GlobeNewswire October 30, 2017